UK Pharma Pays Over €200M for a German Drug Against Biliary Cancer
Mundipharma has acquired the rights to CAP7.1, a drug that could bring the first alternative…
14/08/2017 - 2 minutes
Virtual biotech
Pinning Down Elusive Targets: Interviewing the Co-Founder & CSO of Heptares
Heptares is expanding into a range of indications with its GPCR platform. I caught up…
17/07/2017 - 6 minutes
Discussing the Virtual Biotech Model with XO1 Co-Founder Trevor Baglin
Academic, entrepreneur and now venture partner Trevor Baglin discusses his successful experience working with…
19/06/2017 - 7 minutes
After its First Success, the Virtual Biotech Team is Back at it Again
SuperX has raised €10.3M ($11M) in Series A from Medicxi and J&J Innovation to develop…
09/02/2017 - 2 minutes
